Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?
Dec 20
Have your own idea? Try our Stock Screener
German (DAX) Healthcare Sector Analysis
UpdatedDec 21, 2024
DataAggregated Company Financials
Companies59
- 7D-3.0%
- 3M-6.2%
- 1Y-12.6%
- YTD-13.3%
Over the last 7 days, the Healthcare industry has dropped 3.0%, driven by a pullback from Siemens Healthineers of 2.6%. The industry has fallen 13% in the last year. Earnings are forecast to grow by 21% annually.
Sector Valuation and Performance
Has the German Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 22 Dec 2024 | €208.8b | €159.3b | €5.0b | 21.4x | 41.7x | 1.3x |
| Tue, 19 Nov 2024 | €207.4b | €159.2b | €5.0b | 21.1x | 41.3x | 1.3x |
| Thu, 17 Oct 2024 | €223.2b | €159.3b | €5.7b | 21.5x | 39.2x | 1.4x |
| Sat, 14 Sep 2024 | €229.5b | €159.2b | €5.6b | 22.4x | 41x | 1.4x |
| Mon, 12 Aug 2024 | €225.6b | €159.1b | €5.6b | 25.7x | 40.1x | 1.4x |
| Wed, 10 Jul 2024 | €221.6b | €158.6b | €3.5b | 24.7x | 62.6x | 1.4x |
| Fri, 07 Jun 2024 | €241.6b | €158.6b | €3.5b | 27x | 68.5x | 1.5x |
| Sun, 05 May 2024 | €231.3b | €159.0b | €3.5b | 25.1x | 66.5x | 1.5x |
| Tue, 02 Apr 2024 | €249.5b | €159.4b | €3.2b | 25.6x | 78x | 1.6x |
| Thu, 29 Feb 2024 | €242.7b | €178.9b | €3.3b | 21x | 72.6x | 1.4x |
| Sat, 27 Jan 2024 | €245.3b | €188.4b | €3.3b | 22.3x | 74.5x | 1.3x |
| Mon, 25 Dec 2023 | €243.0b | €188.4b | €3.3b | 21.8x | 74.3x | 1.3x |
| Wed, 22 Nov 2023 | €243.1b | €188.4b | €3.3b | 23.4x | 74x | 1.3x |
| Fri, 20 Oct 2023 | €237.2b | €189.6b | €8.8b | 21.6x | 27x | 1.3x |
| Sun, 17 Sep 2023 | €259.6b | €189.5b | €8.8b | 22.8x | 29.6x | 1.4x |
| Tue, 15 Aug 2023 | €266.8b | €189.4b | €8.9b | 24.7x | 30x | 1.4x |
| Thu, 13 Jul 2023 | €258.0b | €191.1b | €10.5b | 23.3x | 24.5x | 1.4x |
| Sat, 10 Jun 2023 | €270.4b | €191.1b | €10.5b | 23.4x | 25.8x | 1.4x |
| Mon, 08 May 2023 | €283.1b | €190.7b | €12.5b | 22.5x | 22.7x | 1.5x |
| Wed, 05 Apr 2023 | €280.5b | €190.5b | €12.6b | 22.1x | 22.2x | 1.5x |
| Fri, 03 Mar 2023 | €276.8b | €189.2b | €13.3b | 17.8x | 20.8x | 1.5x |
| Sun, 29 Jan 2023 | €285.4b | €187.6b | €13.9b | 17.9x | 20.6x | 1.5x |
| Tue, 27 Dec 2022 | €261.5b | €187.5b | €13.9b | 21.4x | 18.8x | 1.4x |
| Thu, 24 Nov 2022 | €272.1b | €186.5b | €13.7b | 21.1x | 19.9x | 1.5x |
| Sat, 22 Oct 2022 | €246.8b | €182.4b | €13.4b | 20x | 18.4x | 1.4x |
| Mon, 19 Sep 2022 | €234.2b | €178.6b | €12.9b | 18.9x | 18.1x | 1.3x |
| Wed, 17 Aug 2022 | €287.4b | €180.8b | €13.4b | 18.9x | 21.4x | 1.6x |
| Fri, 15 Jul 2022 | €275.8b | €178.4b | €11.3b | 23.3x | 24.4x | 1.5x |
| Sun, 12 Jun 2022 | €292.8b | €185.9b | €11.4b | 23.9x | 25.7x | 1.6x |
| Tue, 10 May 2022 | €280.3b | €182.6b | €10.1b | 22.9x | 27.7x | 1.5x |
| Thu, 07 Apr 2022 | €319.2b | €179.7b | €10.0b | 24.9x | 31.8x | 1.8x |
| Sat, 05 Mar 2022 | €288.9b | €178.3b | €9.7b | 21.5x | 29.9x | 1.6x |
| Mon, 31 Jan 2022 | €319.2b | €175.4b | €9.3b | 25.5x | 34.5x | 1.8x |
| Wed, 29 Dec 2021 | €353.9b | €175.4b | €9.3b | 29.7x | 38.2x | 2x |
Price to Earnings Ratio
38.2x
Current Industry PE
- Investors are optimistic on the German Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 41.7x which is higher than its 3-year average PE of 38.2x.
- The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 19% per year over the last three years,
- Revenues have also declined 3.2% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare sector?
| DE Market | -2.58% | |
| Healthcare | -2.96% | |
| Healthtech | 1.09% | |
| Pharma | -2.51% | |
| Medical Equipment | -2.88% | |
| Biotech | -2.93% | |
| Healthcare Services | -3.49% | |
| Life Sciences | -4.49% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio of 66.1x.
- Analysts are expecting annual earnings growth of 33.2%, which is higher than its past year's earnings decline of 1.4% per year.
- Investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 33.9x.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 33% over the next 5 years.
- This is better than its past earnings decline of 1.4% per year.
- In contrast, the Medical Equipment industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1SXP SCHOTT Pharma KGaA | €24.32 | 1.3% +€48.2m | -27.2% | PE24.5x | |
| EVT Evotec | €8.41 | 1.6% +€23.0m | -60.1% | PS1.9x | |
| PHH2 Paul Hartmann | €222.00 | 2.8% +€21.3m | 10.4% | PE13.2x | |
| NXU Nexus | €69.90 | 1.6% +€19.0m | 17.7% | PE45.1x | |
| DMP Dermapharm Holding | €38.00 | 0.8% +€16.2m | -9.2% | PE22.6x |
